Saturday 17 October 2026
Export SRTS’s income statement to Excel — free account
Sensus Healthcare, Inc.
SRTS Healthcare Medical Devices
Sensus Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $27.5 million, down 34.3% from fiscal 2024. In the quarter to June 2026, revenue fell 68.7%, EPS fell 783.3% and free cash flow fell 201.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.77
0.00
0.00%
Follow SRTS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 4 | 6 | 6 | 2 | 3 | 3 | 3 | 4 |
P/E ratio |
0.00 | 17.30 | 83.00 | 4.83 | 30.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
8.85 | 13.07 | 6.35 | 11.23 | 12.89 | 4.98 | 4.74 | 10.20 | 6.14 | 11.29 |
P/S ratio |
2.36 | 2.70 | 1.66 | 2.61 | 4.40 | 6.62 | 2.11 | 3.96 | 3.66 | 4.26 |
P/FCF ratio |
195.73 | 0.00 | 0.00 | 8.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
14.36 | 16.19 | 16.43 | 13.21 | 8.58 | 3.68 | 6.48 | 7.47 | 2.93 | 7.43 |
P/Operating CF |
(29.44) | (136.49) | 15.17 | (11.49) | (66.83) | (176.21) | 124.92 | (63.30) | 94.92 | 42.34 |
Beneish M-Score |
(3.66) | (1.10) | (2.32) | 1.67 | (0.41) | (4.40) | (1.28) | (0.30) | (2.76) | (1.71) |
P/B ratio |
1.35 | 2.02 | 0.83 | 2.42 | 4.57 | 2.95 | 2.05 | 3.95 | 6.46 | 4.13 |
Price to Tangible BV |
1.35 | 2.02 | 0.83 | 2.42 | 4.60 | 3.00 | 2.08 | 4.02 | 6.77 | 4.30 |
EV/Sales |
1.77 | 2.31 | 0.95 | 2.17 | 4.08 | 5.68 | 1.75 | 3.60 | 3.31 | 3.53 |
EV/EBITDA |
0.00 | 11.34 | 293.40 | 6.29 | 23.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
92.31 | (116.32) | (10.81) | (68.35) | (385.59) | (125.28) | (22.70) | (11.10) | (22.28) | (61.48) |
EV/FCF |
146.81 | (87.32) | (9.94) | 7.19 | (702.42) | (68.56) | (19.07) | (10.09) | (20.36) | (46.02) |
Quick Ratio |
5.96 | 7.10 | 8.02 | 5.56 | 4.47 | 3.85 | 4.56 | 4.73 | 3.32 | 3.99 |
Current Ratio |
9.72 | 9.64 | 11.76 | 6.92 | 5.24 | 5.18 | 5.26 | 5.30 | 3.68 | 4.58 |
Net Debt/EBITDA |
2.28 | (2.59) | (293.01) | (1.66) | (3.07) | 1.98 | 10.89 | 11.41 | 2.70 | 451.17 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 11.76% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.00 |
Asset Turnover |
0.48 | 0.72 | 0.44 | 1.00 | 0.90 | 0.30 | 0.78 | 1.01 | 1.09 | 1.04 |
Operating CF/Net income |
(0.07) | (0.12) | (4.42) | (0.06) | (0.07) | 0.06 | 1.24 | 4.23 | 0.82 | 2.46 |
Capex/Depreciation |
(0.31) | (0.64) | (0.41) | 29.16 | 0.21 | (0.50) | (0.73) | (1.30) | (0.74) | (0.85) |
Interest Coverage |
— | — | — | 7,415.50 | 2,060.00 | (588.14) | (7.34) | (12.80) | (53.95) | (16.58) |
| (14.85%) | 12.70% | 1.00% | 65.45% | 17.34% | (27.62%) | (6.24%) | (10.61%) | (27.53%) | (3.27%) | |
| (13.40%) | 11.47% | 0.88% | 54.50% | 13.67% | (21.06%) | (4.84%) | (7.77%) | (19.64%) | (2.42%) | |
ROIC |
(24.76%) | 14.97% | (0.93%) | 41.11% | 22.40% | (78.10%) | (9.83%) | (11.31%) | (85.89%) | (6.02%) |
Return on Tangible Assets |
(17.89%) | 12.58% | 1.06% | 52.95% | 15.91% | (31.54%) | (5.94%) | (7.56%) | (27.66%) | (2.56%) |
Average Days of Receivables |
80.23 | 172.26 | 159.21 | 141.79 | 163.72 | 143.91 | 187.58 | 181.57 | 87.91 | 76.36 |
Research and Development Expense of Revenue |
28.30% | 10.08% | 15.07% | 7.77% | 12.71% | 43.42% | 23.54% | 23.69% | 26.67% | 12.32% |
Selling, General and Administrative Expense of Revenue |
52.38% | 29.00% | 44.11% | 25.46% | 34.88% | 97.37% | 48.08% | 47.89% | 58.42% | 56.61% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 |
Share Based Compensation of Revenue |
1.07% | 0.77% | 1.34% | 0.42% | 1.53% | 4.03% | 2.28% | 3.72% | 1.97% | 4.90% |
Graham Net Nets |
0.63 | 0.45 | 1.10 | 0.38 | 0.21 | 0.29 | 0.44 | 0.24 | 0.14 | 0.21 |
Graham Number |
0.00 | 5.55 | 1.42 | 9.79 | 2.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(11.81%) | 5.78% | 1.20% | 20.71% | 3.32% | (10.88%) | (2.91%) | (1.89%) | (4.91%) | (0.61%) |
Free Cash Flow Yield |
0.51% | (0.98%) | (5.76%) | 11.56% | (0.13%) | (1.25%) | (4.36%) | (9.00%) | (4.43%) | (1.80%) |
Revenue per Share |
1.68 | 2.56 | 1.50 | 2.70 | 1.64 | 0.58 | 1.68 | 1.87 | 1.56 | 1.23 |
Operating CF per Share |
0.03 | (0.05) | (0.13) | (0.09) | (0.02) | (0.03) | (0.13) | (0.61) | (0.23) | (0.07) |
Capex per Share |
(0.01) | (0.02) | (0.01) | 0.90 | 0.01 | (0.02) | (0.02) | (0.06) | (0.02) | (0.02) |
Free Cash Flow per Share |
0.02 | (0.07) | (0.14) | 0.81 | (0.01) | (0.05) | (0.15) | (0.67) | (0.25) | (0.09) |
Cash per Share |
1.35 | 1.35 | 1.42 | 1.55 | 0.88 | 0.91 | 0.95 | 1.09 | 0.85 | 0.96 |
Shareholders Equity per Share |
2.95 | 3.42 | 3.00 | 2.92 | 1.58 | 1.31 | 1.73 | 1.87 | 0.88 | 1.27 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.95 | 3.42 | 3.00 | 2.92 | 1.58 | 1.31 | 1.73 | 1.87 | 0.88 | 1.27 |
Free Cash Flow |
0.33 | (1.11) | (2.33) | 13.43 | (0.16) | (0.79) | (2.51) | (9.42) | (3.34) | (1.14) |
Working Capital |
41.17 | 50.85 | 45.32 | 45.54 | 25.28 | 20.32 | 27.53 | 25.88 | 13.02 | 13.10 |
Capital Expenditures |
(0.20) | (0.28) | (0.19) | 14.84 | 0.13 | (0.36) | (0.40) | (0.85) | (0.29) | (0.29) |
Net Current Asset Value |
40.95 | 50.40 | 44.66 | 44.58 | 25.02 | 18.66 | 25.08 | 25.11 | 10.73 | 13.09 |
EV/EBIT |
0.00 | 11.95 | 0.00 | 6.51 | 26.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.01 | (0.33) | 0.00 | 0.04 | 0.01 | 0.03 | 0.01 | 0.02 |
Price to Operating Income |
0.00 | 13.95 | 0.00 | 7.83 | 28.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.32 | 0.22 | 0.99 | 2.09 | 1.01 | 0.53 | 0.50 | 0.74 | 0.98 | 0.78 |
Cash ROIC |
0.47% | (1.42%) | (3.24%) | 18.25% | (0.39%) | (2.18%) | (5.76%) | (22.51%) | (13.33%) | (4.25%) |
Accounts Receivable Turnover |
2.13 | 2.75 | 1.75 | 3.03 | 3.40 | 1.08 | 2.01 | 2.92 | 5.11 | 5.73 |
Accounts Payable Turnover |
3.83 | 4.57 | 2.49 | 3.11 | 2.90 | 1.13 | 1.95 | 2.06 | 1.99 | 1.96 |
Inventory Turnover |
1.06 | 1.23 | 0.84 | 2.59 | 3.25 | 1.17 | 4.20 | 6.80 | 5.60 | 4.41 |
Average Days of Payables |
78.14 | 101.06 | 98.54 | 135.21 | 147.32 | 242.38 | 179.73 | 198.15 | 218.74 | 203.06 |
Days of Inventory on Hand |
375.99 | 282.40 | 523.84 | 239.07 | 63.86 | 373.35 | 112.71 | 62.47 | 62.99 | 92.25 |
Average Receivables |
12.89 | 15.19 | 13.97 | 14.71 | 7.95 | 8.89 | 13.58 | 9.05 | 4.03 | 2.59 |
Average Payables |
4.08 | 3.80 | 4.16 | 4.79 | 3.47 | 3.83 | 4.97 | 4.62 | 3.42 | 2.53 |
Average Inventory |
14.76 | 14.15 | 12.30 | 5.76 | 3.09 | 3.71 | 2.31 | 1.40 | 1.21 | 1.13 |
Average Assets |
57.60 | 57.94 | 55.22 | 44.49 | 30.13 | 32.47 | 35.09 | 26.04 | 18.89 | 14.29 |
Average Common Equity |
51.96 | 52.33 | 48.46 | 37.04 | 23.76 | 24.75 | 27.23 | 19.07 | 13.48 | 10.60 |
Columns are period end dates